Immunopathology of chronic rhinosinusitis

A Kato - Allergology International, 2015 - jstage.jst.go.jp
abstract Chronic rhinosinusitis (CRS) is a heterogeneous disease characterized by local
inflammation of the upper airways and sinuses which persists for at least 12 weeks. CRS …

B cell signaling and fate decision

T Kurosaki, H Shinohara, Y Baba - Annual review of …, 2009 - annualreviews.org
Antigen receptors on the surface of B lymphocytes trigger adaptive immune responses after
encountering their cognate antigens but also control a series of antigen-independent …

[HTML][HTML] CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation

MC Kowarik, S Cepok, J Sellner, V Grummel… - Journal of …, 2012 - Springer
Background The chemokines and cytokines CXCL13, CXCL12, CCL19, CCL21, BAFF and
APRIL are believed to play a role in the recruitment of B cells to the central nervous system …

Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity

A Kato, RP Schleimer - Current opinion in immunology, 2007 - Elsevier
It has become increasingly clear that airway epithelial cells are central participants in innate
and adaptive immune responses as well as mucosal inflammation. Epithelial cells produce …

Effect of long‐term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double‐blind, placebo‐controlled, dose‐ranging study

AM Jacobi, W Huang, T Wang… - … : Official Journal of …, 2010 - Wiley Online Library
Objective To understand the effects of long‐term BLyS inhibition in human systemic lupus
erythematosus (SLE). Methods Seventeen patients with SLE who were enrolled in a clinical …

[HTML][HTML] TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor

S Gardam, F Sierro, A Basten, F Mackay, R Brink - Immunity, 2008 - cell.com
Tumor necrosis factor receptor-associated factors 2 and 3 (TRAF2 and TRAF3) were shown
to function in a cooperative and nonredundant manner to suppress nuclear factor-κB2 (NF …

Autoimmunity in common variable immunodeficiency

S Agarwal, C Cunningham-Rundles - Current allergy and asthma reports, 2009 - Springer
Common variable immunodeficiency (CVID) is the most common clinically significant
primary immune defect. Although the hallmark of CVID is hypogammaglobulinemia, the …

BAFF: a local and systemic target in autoimmune diseases

I Moisini, A Davidson - Clinical & Experimental Immunology, 2009 - academic.oup.com
BAFF (B lymphocyte activating factor of the tumour necrosis factor family) is a vital
homeostatic cytokine for B cells that helps regulate both innate and adaptive immune …

Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils

P Scapini, F Bazzoni, MA Cassatella - Immunology letters, 2008 - Elsevier
The expression and production of cytokines by cells of the innate immune system, including
monocytes/macrophages, dendritic and NK cells, play a critical role not only in defensive …

Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase II, randomized, placebo‐controlled trial

RF Van Vollenhoven, N Kinnman… - Arthritis & …, 2011 - Wiley Online Library
Objective To assess the efficacy, safety, and biologic activity of atacicept in tumor necrosis
factor antagonist–naive patients with rheumatoid arthritis (RA) in whom the response to …